deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT01307267

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

A PHASE 1 STUDY OF PF-05082566 AS A SINGLE AGENT IN PATIENTS WITH ADVANCED CANCER, AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL)

Sponsor: Pfizer

Conditions Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Carcinoma, Squamous Cell of Head and Neck Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Malignant Melanoma
Interventions PF-05082566 rituximab
Updated 22 times since 2017 Last updated: Mar 4, 2020 Started: Jun 21, 2011 Primary completion: Feb 20, 2019 Completion: Feb 20, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01307267, this PHASE1 trial focuses on Carcinoma, Non-Small-Cell Lung and Carcinoma, Renal Cell and remains completed. Sponsored by Pfizer, it has been updated 22 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jun 2017 · 3 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Nov 2017 · 3 months · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Oct 2018 · 2 months · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Apr 2020 · 10 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 9 months · monthly snapshot

Change History

22 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 17 earlier versions

  1. Jun 2019 — Apr 2020 [monthly]

    Completed PHASE1

  2. May 2019 — Jun 2019 [monthly]

    Completed PHASE1

  3. Apr 2019 — May 2019 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Mar 2019 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1

  5. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting PHASE1

  6. Nov 2018 — Feb 2019 [monthly]

    Active Not Recruiting PHASE1

  7. Oct 2018 — Nov 2018 [monthly]

    Active Not Recruiting PHASE1

  8. Aug 2018 — Oct 2018 [monthly]

    Active Not Recruiting PHASE1

  9. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE1

  10. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  11. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  12. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE1

  13. Aug 2017 — Nov 2017 [monthly]

    Recruiting PHASE1

  14. Jun 2017 — Aug 2017 [monthly]

    Recruiting PHASE1

  15. Mar 2017 — Jun 2017 [monthly]

    Recruiting PHASE1

  16. Feb 2017 — Mar 2017 [monthly]

    Recruiting PHASE1

  17. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Jun 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akita, Japan , Ann Arbor, United States , Atlanta, United States , Bologna, Italy , Boston, United States , City of Saint Peters, United States , Creve Coeur, United States , Duarte, United States , Houston, United States , Kashiwa, Japan and 15 more locations